Navigation Links
Bion Announces New U.S. Patent for Phosphorus Removal
Date:8/11/2011

NEW YORK, Aug. 11, 2011 /PRNewswire/ -- Bion Environmental Technologies, Inc. (OTC BB/QX: BNET) announced today that it has been notified by the United States Patent and Trademark Office that the patent application entitled "Micro-Electron Acceptor Phosphorus Accumulating Organisms" has been granted. 

The new patent provides enhanced protection for Bion's micro-aerobic digestion process's nutrient uptake capabilities with respect to the removal of phosphorus from livestock waste, as well as a wide range of other waste streams.  The new patent strengthens Bion's patent portfolio by describing the unique ability of the technology's process to use phosphorus accumulating organisms to convert and remove phosphorus, while maintaining nitrogen removal.   

Bion's technology employs a biological nutrient removal process driven by the system's active microbial community that utilizes and metabolizes the waste stream to convert potential pollutants to benign forms that can then be removed from the effluent discharge stream and potentially converted into energy or other valuable by-products. With the publication of this newly granted patent, the Company's present IP portfolio includes six U.S. patents, as well as patents in Canada, New Zealand and Mexico.  Two additional U.S. patents have been applied for and are pending, along with international patent applications under consideration for the European Union, Brazil, Argentina and Australia.

James Morris, Ph.D., P. E., Bion's Chief Technology Officer, stated, "The strength of Bion's patent portfolio continues to grow, this time with expanded protections for the types of microorganisms employed, as well as details on the nutrient removal quantities, by the Bion process.  Bion now has in hand a very broad array of patents, many of them recently issued, which protect variations and enhancements of the core Bion process."

About Bion: Bion Environmental Technologies has
'/>"/>

SOURCE Bion Environmental Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ViaCyte Announces Executive Management Changes
2. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
3. Dendreon Announces Webcast Presentation at Canaccord Genuity Growth Conference
4. Osteologix Announces Completion of Corporate Consolidation
5. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2011 Results
6. Palatin Announces Commencement of a Phase 1 Trial for Obesity Compound in Collaboration with AstraZeneca
7. Rigel Announces Second Quarter 2011 Financial Results
8. WAVi Co. Announces Collaborative Agreement with SomaLogic, Inc.
9. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
10. International Isotopes Inc. Announces Successful International Standards Certification for Manufacture of Its Nuclear Medicine Products and Devices
11. Biocept, Inc. Announces Availability of Its New Breast Cancer Test, OncoCEE-BR™ Utilizing Circulating Tumor Cells (CTCs)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... BETHESDA, Md. , July 24, 2014  Spherix ... to the fostering and monetization of intellectual property, today ... for the period ending June 30, 2014 on Monday, ... conference call at 10 a.m. ET on Monday, August ... to be led by the company,s CEO, Anthony ...
(Date:7/24/2014)... Brook, NJ (PRWEB) July 24, 2014 ... to manage numerous projects in the MENA region during ... to have a preferred provider agreement with DZS to ... the MENA region,” said Global VP of R&D and ... "DZS has developed excellent operational practices with a focus ...
(Date:7/23/2014)... , July 24, 2014 Lyfebulb, ... Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North ... or "the Company"), announced a collaboration to increase ... last night at an event attended by more ... parties. Lyfebulb is a health and wellness company ...
(Date:7/23/2014)... Inc. (NASDAQ: SGMO ) today reported its ... For the second quarter ended June 30, 2014, ... or $0.10 per share, compared to a net loss ... same period in 2013. As of June 30, 2014, ... interest receivable of $236.7 million. Revenues for ...
Breaking Biology Technology:Spherix Schedules Shareholder Update Call 2SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9
... 2011 Reportlinker.com announces that a new market ... Global Biotechnology Reagents Industry ... report analyzes the worldwide markets for Biotechnology Reagents ... Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, ...
... Feb. 23, 2011 Ingenuity® Systems, a leading ... science researchers, today announced a research collaboration with ... sequencing (NGS) data analysis. Covance Genomics Laboratory, a ... discovery and development industry, and Ingenuity will work ...
... State University have developed a faster, easier way ... by using liquid metal. Microfluidic devices manipulate small ... of applications, from testing minute blood samples to ... easier to incorporate electrodes into microfluidic devices, we ...
Cached Biology Technology:Reportlinker Adds Global Biotechnology Reagents Industry 2Ingenuity Systems and Covance Collaborate to Support Next-Generation Sequencing Research 2Liquid metal key to simpler creation of electrodes for microfluidic devices 2
(Date:7/24/2014)... Forest is a hotspot of biodiversity and one of ... and toads) in the world. However, current levels of ... years has been an increase in the description of ... advance of molecular techniques and availability of samples for ... of samples for molecular and morphological analysis, researchers from ...
(Date:7/24/2014)... Neiker-Tecnalia is currently conducting research into the potato genes ... characterised by a reduction in rainfall and increased extremes ... the most resistant genes in order to create new ... conditions.The research is also seeking to find out how ... of greater drought and higher and lower temperatures. , ...
(Date:7/24/2014)... German . ... sufferers worldwide, a further 600 million people living with ... population contending with allergic rhinitis (allergic inflammation of the ... organs and parts of the body beyond the respiratory ... form of inflammatory bowel diseases such as colitis ulcerosa), ...
Breaking Biology News(10 mins):A tiny new species of frog from Brazil with a heroic name 2Neiker-Tecnalia is researching the potato genes that best adapt to climate change 2New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3
... of Genes & Development, Dr. Karlene Cimprich and colleagues ... sufficient to activate the ATR-mediated DNA damage checkpoint. ... Dr. Cimprich. "The ability to precisely define and manipulate ... experimental system will enable us to control, quantitative and ...
... to preserve grapes could help prevent allergies and boost healthy ... & Industry, the magazine of the SCI. The same technique ... wines without the added sulphites that can cause asthma and ... remain in storage for months and are usually treated with ...
... knowledge of the properties and actions of enzymes, scientists have ... originally isolated from blue-green algae. , This accomplishment is ... promising drugs for use in clinical trials. , In ... of the journal ACS Chemical Biology, a scientific team lead ...
Cached Biology News:Grape expectations for healthier wine 2Turning green gunk to gold, anti-cancer gold 2
... power of your ValveBank system! Program ... a Macintosh computer using graphic 'click-and-drag' timebars. ... print out program listings, then download your ... simple step., EasyCode is used for programming ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
... MSC series of Class II Biological ... and certification to the world's highest ... that the cabinets cannot be adjusted ... lighting, low noise and arm rest ...
... Fluoroskan Ascent is a dedicated ... for all kinds of assays ... and for clinical applications. Cell ... are all important application areas. ...
Biology Products: